| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.24B | -2.3% |
| R&D Expense | $177.1M | -11.5% |
| SG&A Expense | $227.3M | +24.3% |
| Operating Income | $307.1M | -78.5% |
| Interest Expense | $188.0M | +13.1% |
| Pre-tax Income | $230.1M | -81.5% |
| Income Tax | $0 | — |
| Net Income | $42.8M | -93.1% |
| EPS (Basic) | $0.10 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.71B | +11.0% |
| Current Assets | $2.55B | -11.2% |
| Total Assets | $16.81B | -4.0% |
| Current Liabilities | $1.17B | +581.3% |
| Long-term Debt | $7.12B | +0.3% |
| Total Liabilities | $7.29B | +0.3% |
| Stockholders' Equity | $9.53B | -7.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.14B | +6.3% |
| Investing Cash Flow | -$1.03B | +45.0% |
| Financing Cash Flow | -$944.9M | -345.3% |
| -93.3% |
| EPS (Diluted) | $0.10 | -93.3% |